BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26844481)

  • 21. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
    Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
    Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
    Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
    Zhang CT; He KC; Pan F; Li Y; Wu J
    World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low expression of AIM2 combined with high expression of p‑STAT3 is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
    Li Z; Shi X; Li H; Wang W; Li X
    Oncol Rep; 2019 Apr; 41(4):2396-2408. PubMed ID: 30816544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
    Lin H; Zhao X; Xia L; Lian J; You J
    Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
    Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
    PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
    Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
    Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
    Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
    PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of STAT3/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis.
    He S; Liao G; Liu Y; Huang L; Kang M; Chen L
    Int J Clin Exp Med; 2015; 8(11):20014-23. PubMed ID: 26884913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of TAZ expression in various cancers: a meta-analysis.
    Feng J; Ren P; Gou J; Li Z
    Onco Targets Ther; 2016; 9():5235-44. PubMed ID: 27601916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
    Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
    PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: a systematic review and meta-analysis.
    Huang JY; Xu YY; Li M; Sun Z; Zhu Z; Song YX; Miao ZF; Wu JH; Xu HM
    Ann Surg Oncol; 2013 Nov; 20(12):3927-34. PubMed ID: 23892524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and Prognostic Roles of STAT3 and Its Phosphorylation in Glioma.
    Liang B; Li SY; Gong HZ; Wang LX; Lu J; Zhao YX; Gu N
    Dis Markers; 2020; 2020():8833885. PubMed ID: 33299498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.